Journey Medical (DERM) Accounts Payables (2020 - 2025)
Historic Accounts Payables for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $11.6 million.
- Journey Medical's Accounts Payables fell 2465.61% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2465.61%. This contributed to the annual value of $16.0 million for FY2024, which is 1156.54% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Accounts Payables is $11.6 million, which was down 2465.61% from $12.8 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's Accounts Payables ranged from a high of $43.7 million in Q1 2023 and a low of $11.6 million during Q3 2025
- For the 5-year period, Journey Medical's Accounts Payables averaged around $23.7 million, with its median value being $22.8 million (2021).
- Its Accounts Payables has fluctuated over the past 5 years, first surged by 114045.68% in 2021, then tumbled by 6485.64% in 2024.
- Quarter analysis of 5 years shows Journey Medical's Accounts Payables stood at $22.8 million in 2021, then skyrocketed by 60.31% to $36.6 million in 2022, then plummeted by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then fell by 27.99% to $11.6 million in 2025.
- Its Accounts Payables was $11.6 million in Q3 2025, compared to $12.8 million in Q2 2025 and $14.4 million in Q1 2025.